Calidi Biotherapeutics, Inc. Liabilities, Noncurrent
Calidi Biotherapeutics, Inc. (CLDI) had Liabilities, Noncurrent of $4.58 million as of 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2023-08-21
- 2023-06-30: Liabilities, Noncurrent $4.58M.
- 2023-03-31: Liabilities, Noncurrent $1.54M.
- 2022-12-31: Liabilities, Noncurrent $1.07M.
- 2022-09-30: Liabilities, Noncurrent $9.03M.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2023-06-30 | $4.58M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $1.54M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.07M 10-Q · filed 2023-08-21 |
| 2022-09-30 | $9.03M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.71M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $14.07M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $16.04M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |